Pituitary tumoursBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6947.130b (Published 09 July 1994) Cite this as: BMJ 1994;309:130
- S J Hurel,
- P Kendall-Taylor,
- P H Baylis
- Registrar in endocrinology Professor of endocrinology Professor of experimental medicine Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP.
EDITOR,—Andrew Levy and Stafford L Lightman review the diagnosis and management of pituitary tumours.1 Our practice differs from theirs in one important aspect.
The authors suggest that if the circulating cortisol concentration increases to over 495 nmol/l in response to 250 µg of tetracosactrin then glucocorticoid replacement is unnecessary. The use …